Novartis Foundation

06.07.2022

The Future of Virtual Health and Care

Driving access and equity through inclusive policies

Novartis Foundation The Novartis Foundation has been co-chairing, along with the World Health Organization, the Broadband Commission for Sustainable Development Working Group on Virtual Health and Care. The working group just published its report ‘The Future of Health and Care’, which delivers a roadmap that describes which policies have enabled a rapid uptake of virtual health and care during the pandemic, to serve as recommendations to help governments and other stakeholders ensure that virtual health and care drives access and equity, rather than entrenching or exacerbating existing divides. Listen to the recording of the live pre-launch event which took place in the HealthTech Hub Africa in Kigali, Rwanda. Please find attached the report, plus the dissemination kit.

03.09.2021

Fostering cardiovascular health at work – case study from Senegal

By Ann Aerts (Novartis Foundation) et al.

BioMed Central Public Health "Of the 15 million annual premature deaths from non-communicable diseases (NCDs), 85% occur in low- and middle-income countries (LMICs). Affecting individuals in the prime of their lives, NCDs impose severe economic damage to economies and businesses, owing to the high mortality and morbidity within the workforce. The Novartis Foundation urban health initiative, Better Hearts Better Cities, was designed to improve cardiovascular health in Dakar, Senegal through a combination of interventions including a workplace health program. In this study, we describe the labor policy environment in Senegal and the outcomes of a Novartis Foundation-supported multisector workplace health coalition bringing together volunteering private companies."

04.06.2021

Launching the CV population health toolkit: Join us to transform cardiovascular population health!

Novartis Foundation "The word ‘pandemic’ is rightly on top of the agendas worldwide. But in reality we’re facing a ‘syndemic’, which is the convergence and interaction between COVID-19 and pre-existing conditions like cardiovascular disease – the world’s biggest killer. This toolkit starts with a needs assessment to discover what policies exist, understand the population at risk, map the patient pathway, and understand what barriers prevent progress toward achieving the priorities of a city's priorities in its efforts to improve cardiovascular (CV) health."

04.05.2021

HealthTech Dialogue Hub

As the Novartis Foundation launches the HealthTec Dialogue Hub, its director of global health policy explains why it's needed and how it will help improve populations health

Devex "Driven by a desire to catalyze AI driven solutions for health and care delivery in low- and middle-income populations, the HealthTech Hub showcases lessons learned around technology-enabled innovations, hosts events and facilitates ongoing dialogue between government leaders, health care workers, and innovators."

29.04.2021

Stopping the Syndemic

The role of tech to ensure cardiovascular health in the COVID-19 era

Novartis Foundation "In addition to the direct health risks of the COVID-19 pandemic, the virus’ indirect effects have also severely disrupted access to basic health services that prevent, diagnose, and treat patients with noncommunicable diseases. Every year, NCDs kill 41 million people — up to 71% of all deaths globally. The majority of these deaths occur in low- and middle-income countries, where health systems are often limited in terms of capacity and resources. (...) Devex hosted a virtual event in partnership with the Novartis Foundation to explore how the global health community can build on this momentum of increased use and trust in virtual health and care services, to leverage technology for improving cardiovascular population health, especially in LMICs."

10.09.2020

Lower-income countries could soon leapfrog high-income countries with AI-enabled health technologies, Novartis Foundation and Microsoft backed report says

Novartis Foundation "Low- and middle-income countries could soon leapfrog high-income countries in their adoption of new AI-enabled technologies in health, suggests a report led by the Novartis Foundation and Microsoft.